Raise by Fusion42
Fusion42 Scout Wire
Capital Reports
Who's InvestingWeekly · Mon 08:00 UTCCapital UnlockedBi-weekly · Wed 08:00 UTC
Benchmarks
Benchmarks HomeFundsRoundsSectors
AI VC IndexCapital FlowAbout

Switch product

Fusion42RaiseScoutWire

Capital Reports

All editionsWho's InvestingWeekly · Mon 08:00 UTCCapital UnlockedBi-weekly · Wed 08:00 UTC

Database & benchmarks

Benchmarks HomeFundsRoundsSectorsStagesAI VC IndexCapital Flow Index

Account

Sign in
← Back

Lotte Holdings | Lotte Healthcare and Biopharmaceutical CVC

corporate vcCo-invests

◆ Check Size

$1.0M→$50.0M

◆ Location

Japan

◆ Portfolio

11 companies

◆ Activity

Statusactively investing

◆ Links

Website ↗

◆ Share this fund

ShareXLinkedInEmail

◆ Investment Thesis

Investment in Korean and global biotechnology companies, with focus on antibodies and antibody-drug conjugates (ADCs). First vehicle established August 2024 with ~10 investments across US, Japan, Taiwan, and Switzerland; second fund expected to close within a year with Korea as a new primary focus.

◆ About Lotte Holdings

LOTTE Holdings launched a healthcare and biopharmaceutical CVC to invest in biopharmaceuticals and next-generation modalities, with a stated goal of gathering cutting-edge insights and accelerating access to innovative technologies.[2] It targets startups globally and across all stages.[2][3]

◆ Sectors

BiotechDrug DiscoveryDiagnosticsMedtech

◆ Stages

pre-seedseedseries-a

◆ Geography Focus

JapanSouth KoreaSwitzerlandTaiwanUnited States

◆ Team

NameTitleRoleLinks
Genichi TamatsukaRepresentative Director & CEOC-level
玉塚 元一 (Genichi Tamatsuka)代表取締役社長 CEO (Representative Director, President & CEO)C-Suite / CEO
重光 昭夫 (Akio Shigemitsu)代表取締役会長 (Representative Director, Chairman)C-Suite / Chairman

◆ Notable Investments

Physiologas TechnologiesMetaphore BiotechnologiesRakuten MedicalMetaphore Biotechnologies, Inc.スモール・プラネット (Small Planet)ClearideBio TherapeuticsAlveus TherapeuticsOmicInsight CorporationCartography BiosciencesElixiron ImmunotherapeuticsLinqmed Inc.Nuvig TherapeuticsLinqmed

◆ Traits

Co-invests

◆ FAQ

What does Lotte Healthcare and Biopharmaceutical CVC invest in?

Lotte Healthcare and Biopharmaceutical CVC invests in Biotech, Drug Discovery, Diagnostics and Medtech at the pre-seed, seed and series-a stages.

Which geographies does Lotte Healthcare and Biopharmaceutical CVC focus on?

Lotte Healthcare and Biopharmaceutical CVC focuses on Japan, South Korea, Switzerland, Taiwan and United States, and is headquartered in Japan.

What is Lotte Healthcare and Biopharmaceutical CVC's typical check size?

Lotte Healthcare and Biopharmaceutical CVC typically writes checks of $1M to $50M.